US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist
  • 136.840
  • -1.530-1.11%
Close Mar 31 16:00 ET
  • 136.840
  • 0.0000.00%
Post 20:01 ET
20.03BMarket Cap12.24P/E (TTM)

About Biogen Company

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Company Profile

SymbolBIIB
Company NameBiogen
Listing DateSep 17, 1991
Issue Price15.00
Founded1978
CEOMr. Christopher A. Viehbacher
MarketNASDAQ
Employees7605
Fiscal Year Ends12-31
Address225 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-679-2000
Websitehttp://www.biogen.com

Company Executives

  • Name
  • Position
  • Salary
  • Christopher A. Viehbacher
  • Director, President and Chief Executive Officer
  • 4.07M
  • Sean Godbout
  • Vice President, Chief Accounting Officer & Global Corporate Controller
  • --
  • Susan H. Alexander
  • Executive Vice President and Chief Legal Officer
  • 6.70M
  • Robin C. Kramer
  • Chief Financial Officer
  • --
  • Dr. Ginger Gregory, PhD
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Nicole Murphy
  • Executive Vice President, Pharmaceutical Operations and Technology
  • 5.71M
  • Rachid Izzar
  • Executive Vice President, Global Product Strategy and Commercialization
  • 5.45M
  • Adam Keeney, PhD
  • Executive Vice President and Head of Corporate Development
  • --
  • Dr. Priya Singhal, M.D.,M.P.H.
  • Executive Vice President and Head of Development
  • --
  • Dr. Jane Grogan, PhD
  • Executive Vice President, Head of Research
  • --
  • Caroline D. Dorsa
  • Chairman of the Board
  • 646.13K
  • Professor Menelas Pangalos, PhD
  • Independent Director
  • --
  • Susan Langer
  • Independent Director
  • 334.53K
  • William A. Hawkins, III
  • Independent Director
  • 425.73K
  • Monish D. Patolawala
  • Independent Director
  • --
  • Jesus B. Mantas
  • Independent Director
  • 433.23K
  • Dr. Stephen A. Sherwin, M.D.
  • Independent Director
  • 435.32K
  • Dr. Maria C. Freire, PhD
  • Independent Director
  • 412.90K
  • Dr. Lloyd Minor
  • Independent Director
  • --
  • Dr. Eric K. Rowinsky,M.D.
  • Independent Director
  • 418.02K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Precision Drilling
PDS
46.620
Lantheus
LNTH
97.600
eBay
EBAY
67.730
4
DexCom
DXCM
68.290
5
Collegium Pharmaceutical
COLL
29.850
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings